BV
Broadview Ventures
Venture CapitalActiveBroadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
45
Investments
3
Exits
$250M
AUM
6.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Broadview Ventures.
Investment Thesis & Strategy
Broadview Ventures invests in technology solutions for cardiovascular and neurovascular diseases, targeting companies across various stages of development. They seek innovative businesses within the healthcare and life science sectors.
Investment Activity
Deals per year over the last 13 years
1
20100
20111
20120
20130
20140
20152
20160
20172
20183
20190
20202
20211
2022Portfolio Companies
Selected investments from their portfolio of 45 companies
V
Vesica Medical
Healthcare · Series A, 2022
C
CereVasc
Healthcare · Series A, 2021
V
Vena Medical
Healthcare · Series A, 2021
I
Insera Therapeutics
Healthcare · Series A, 2019
V
Vektor Medical
Healthcare · Series A, 2019
C
Coronary Artery Technologies
Healthcare · Series A, 2019
V
Vascular Therapies
Healthcare · Series A, 2018
R
Rapid Medical
Healthcare · Series A, 2018
S
Soundbite Medical Solutions
Healthcare · Series A, 2016
E
Endotronix
Healthcare · Series B, 2016
C
Claret Medical
Healthcare · Series A, 2012
H
HeartFlow
Healthcare · Series B, 2010
Notable Exits
CompanyTypeYearValue / Acquirer
CleerlyAcquisition2024—
HeartFlowAcquisition2023$700M
Corvus HealthAcquisition2023—
Frequently Asked Questions
Broadview Ventures focuses on Series A, Series B, Series C+ stage investments.